Form 4: Reprogrammed Interchange Sells VOR Biopharma Shares

Reprogrammed Interchange LLC and Reid Hoffman reported significant sales of Vor Biopharma Inc. common stock in mid-October 2025, reducing their beneficial ownership.

Summary

• Reprogrammed Interchange LLC, a 10% owner and director of Vor Biopharma Inc. (VOR), disposed of a total of 73,676 shares of common stock.
• The sales occurred on October 15, 2025, and October 16, 2025.
• The shares were sold at weighted average prices ranging from $30.4548 to $32.7733 per share.
• Following these transactions, Reprogrammed Interchange LLC's beneficial ownership decreased to 1,204,442 shares.
• Reid Hoffman, also a director and 10% owner, is deemed a beneficial owner of these securities through his shared control and indirect pecuniary interest in Reprogrammed Interchange LLC.

Sentiment

Score: 3

Explanation: The sentiment is negative due to significant insider selling by a director and 10% owner, which typically signals reduced confidence in the company's near-term prospects or valuation.

Negatives

• Significant insider selling by a 10% owner and director (Reprogrammed Interchange LLC and Reid Hoffman) can be perceived as a negative signal regarding the company's future prospects or valuation.
• The reduction in beneficial ownership by a key insider may indicate a lack of confidence or a strategic shift away from the company.

Future Outlook

NA

Industry Context

This filing is a standard insider transaction report and does not provide specific industry context or updates on Vor Biopharma Inc.'s operational performance or strategic position within the biotechnology sector. It primarily reflects a change in a significant shareholder's investment posture.

Related Party Transactions

• Reprogrammed Interchange LLC, a 10% owner and director, sold shares of Vor Biopharma Inc. common stock.

Stakeholder Impact

• Shareholders may interpret the insider selling as a negative indicator, potentially leading to decreased investor confidence and downward pressure on the stock price.

Key Dates

Recommendation

The significant sale of shares by a 10% owner and director, Reprogrammed Interchange LLC (associated with Reid Hoffman), typically signals a lack of confidence from a key insider. Such insider selling can be a strong negative indicator for investors, suggesting that the insider believes the stock may be overvalued or that future prospects are dim. A seasoned investor would likely view this as a reason to reduce or exit their position, hence a 'sell' recommendation.

Keywords

VOR Biopharma, Insider Trading, Form 4, Stock Sale, Reprogrammed Interchange LLC, Reid Hoffman, Beneficial Ownership, Director Transaction